Statin Prices Likely To Remain High After Zocor Exclusivity Win
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva and Ranbaxy appear slated for 180 days of simvastatin exclusivity after federal court ruling postponing mass generic entry into the sector until 2007.